173 related articles for article (PubMed ID: 11500028)
21. Enhanced sialylation of recombinant human erythropoietin in Chinese hamster ovary cells by combinatorial engineering of selected genes.
Son YD; Jeong YT; Park SY; Kim JH
Glycobiology; 2011 Aug; 21(8):1019-28. PubMed ID: 21436238
[TBL] [Abstract][Full Text] [Related]
22. Reversible sialylation: synthesis of cytidine 5'-monophospho-N-acetylneuraminic acid from cytidine 5'-monophosphate with alpha2,3-sialyl O-glycan-, glycolipid-, and macromolecule-based donors yields diverse sialylated products.
Chandrasekaran EV; Xue J; Xia J; Locke RD; Matta KL; Neelamegham S
Biochemistry; 2008 Jan; 47(1):320-30. PubMed ID: 18067323
[TBL] [Abstract][Full Text] [Related]
23. Modulation of circulatory residence of recombinant acetylcholinesterase through biochemical or genetic manipulation of sialylation levels.
Chitlaru T; Kronman C; Zeevi M; Kam M; Harel A; Ordentlich A; Velan B; Shafferman A
Biochem J; 1998 Dec; 336 ( Pt 3)(Pt 3):647-58. PubMed ID: 9841877
[TBL] [Abstract][Full Text] [Related]
24. Ammonium alters N-glycan structures of recombinant TNFR-IgG: degradative versus biosynthetic mechanisms.
Gawlitzek M; Ryll T; Lofgren J; Sliwkowski MB
Biotechnol Bioeng; 2000 Jun; 68(6):637-46. PubMed ID: 10799988
[TBL] [Abstract][Full Text] [Related]
25. Expression of beta-galactoside alpha 2,6-sialyltransferase does not alter the susceptibility of human colon cancer cells to NK-mediated cell lysis.
Dall'Olio F; Mariani E; Tarozzi A; Meneghetti A; Chiricolo M; Lau JT; Facchini A
Glycobiology; 1997 Jun; 7(4):507-13. PubMed ID: 9184831
[TBL] [Abstract][Full Text] [Related]
26. NMR characterization of immunoglobulin G Fc glycan motion on enzymatic sialylation.
Barb AW; Meng L; Gao Z; Johnson RW; Moremen KW; Prestegard JH
Biochemistry; 2012 Jun; 51(22):4618-26. PubMed ID: 22574931
[TBL] [Abstract][Full Text] [Related]
27. Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains.
Lund J; Takahashi N; Pound JD; Goodall M; Jefferis R
J Immunol; 1996 Dec; 157(11):4963-9. PubMed ID: 8943402
[TBL] [Abstract][Full Text] [Related]
28. Integrated Genome and Protein Editing Swaps α-2,6 Sialylation for α-2,3 Sialic Acid on Recombinant Antibodies from CHO.
Chung CY; Wang Q; Yang S; Yin B; Zhang H; Betenbaugh M
Biotechnol J; 2017 Feb; 12(2):. PubMed ID: 27943633
[TBL] [Abstract][Full Text] [Related]
29. B-cell-independent sialylation of IgG.
Jones MB; Oswald DM; Joshi S; Whiteheart SW; Orlando R; Cobb BA
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):7207-12. PubMed ID: 27303031
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of glycosylation by stable co-expression of two sialylation-related enzymes on Chinese hamster ovary cells.
Thi Sam N; Misaki R; Ohashi T; Fujiyama K
J Biosci Bioeng; 2018 Jul; 126(1):102-110. PubMed ID: 29439861
[TBL] [Abstract][Full Text] [Related]
31. Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G.
Ogata S; Shimizu C; Franco A; Touma R; Kanegaye JT; Choudhury BP; Naidu NN; Kanda Y; Hoang LT; Hibberd ML; Tremoulet AH; Varki A; Burns JC
PLoS One; 2013; 8(12):e81448. PubMed ID: 24324693
[TBL] [Abstract][Full Text] [Related]
32. Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality.
Scallon BJ; Tam SH; McCarthy SG; Cai AN; Raju TS
Mol Immunol; 2007 Mar; 44(7):1524-34. PubMed ID: 17045339
[TBL] [Abstract][Full Text] [Related]
33. Up-regulation of alpha2,6 sialylation during myeloid maturation: a potential role in myeloid cell release from the bone marrow.
Le Marer N; Skacel PO
J Cell Physiol; 1999 Jun; 179(3):315-24. PubMed ID: 10228950
[TBL] [Abstract][Full Text] [Related]
34. Engineering a bacterial sialyltransferase for di-sialylation of a therapeutic antibody.
Wang M; Wang Y; Liu K; Dou X; Liu Z; Zhang L; Ye XS
Org Biomol Chem; 2020 Apr; 18(15):2886-2892. PubMed ID: 32236230
[TBL] [Abstract][Full Text] [Related]
35. Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers.
Lu J; Gu J
Molecules; 2015 Apr; 20(5):7509-27. PubMed ID: 25919275
[TBL] [Abstract][Full Text] [Related]
36. ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.
Scott E; Archer Goode E; Garnham R; Hodgson K; Orozco-Moreno M; Turner H; Livermore K; Putri Nangkana K; Frame FM; Bermudez A; Jose Garcia Marques F; McClurg UL; Wilson L; Thomas H; Buskin A; Hepburn A; Duxfield A; Bastian K; Pye H; Arredondo HM; Hysenaj G; Heavey S; Stopka-Farooqui U; Haider A; Freeman A; Singh S; Johnston EW; Punwani S; Knight B; McCullagh P; McGrath J; Crundwell M; Harries L; Heer R; Maitland NJ; Whitaker H; Pitteri S; Troyer DA; Wang N; Elliott DJ; Drake RR; Munkley J
J Pathol; 2023 Sep; 261(1):71-84. PubMed ID: 37550801
[TBL] [Abstract][Full Text] [Related]
37. Alpha2,6-sialylation of cell-surface N-glycans inhibits glioma formation in vivo.
Yamamoto H; Oviedo A; Sweeley C; Saito T; Moskal JR
Cancer Res; 2001 Sep; 61(18):6822-9. PubMed ID: 11559557
[TBL] [Abstract][Full Text] [Related]
38. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
[TBL] [Abstract][Full Text] [Related]
39. [Effect of cell surface sialic acid and their linkages on adhesion of mammary carcinoma cells].
Wang XY; Lin SQ; Li JW; Kemmner W; Ding YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):742-6. PubMed ID: 16793589
[TBL] [Abstract][Full Text] [Related]
40. Establishment of a glycoengineered CHO cell line for enhancing antennary structure and sialylation of CTLA4-Ig.
Lim JH; Kim J; Cha HM; Kang SH; Han HJ; Ji M; Cheon SH; Kang M; Kim HH; Kim DI
Enzyme Microb Technol; 2022 Jun; 157():110007. PubMed ID: 35219175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]